A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)

计划入组 84 人 · 首次发布于 2023 年 3 月 23 日

A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)

计划入组 24 人 · 首次发布于 2022 年 10 月 6 日

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Zetomipzomib in Patients with Active Lupus Nephritis

计划入组 0 人

Zetomipzomib

C₃₀H₄₂N₄O₈

ZETOMIPZOMIB MALEATE

[18F]CETO

Zeno Alpha, Inc.

United States

Zeno Pharmaceuticals, Inc.

United States

ZENO FUNCTIONAL FOODS, LLC

United States

Zeto Receives FDA Clearance for New Wave EEG System to Address Outpatient Neurodiagnostic Delays

Johnson & Johnson MedTech Temporarily Pauses U.S. Varipulse Cases

FDA Places Partial Clinical Hold on Kezar's Autoimmune Hepatitis Trial of Zetomipzomib